IHS Chemical Week

People & Business :: Companies

Mylan to Acquire Remaining Stake in Indian API Subsidiary for $133 million

3:53 AM MDT | March 27, 2009 | Deepti Ramesh

Mylan (Canonsburg, PA) says it plans to purchase the remaining interest in its Matrix Laboratories (Secunderabad, India) subsidiary from minority shareholders for a total of about $133 million, and also delist Matrix from the Indian stock exchanges. Mylan currently owns 71.2% of Matrix. Matrix manufactures active pharmaceutical ingredients (APIs) and finished dosage forms, and it will be delisted from the Bombay Stock Exchange, and the National Stock Exchange of India. “Purchasing the remaining interest in Matrix and delisting it from the exchanges will...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa